The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

Share Price Information for H&t Group Plc (HAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 421.00
Ask: 429.00
Change: 1.00 (0.24%)
Spread: 8.00 (1.90%)
Open: 428.00
High: 428.00
Low: 421.00
Prev. Close: 424.00
HAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on regulatory review into HCST lending

4 Apr 2022 07:00

RNS Number : 0372H
H&T Group PLC
04 April 2022
 

H&T Group plc

("H&T" or "the Group" or "the Company")

 

Update in respect of regulatory review into high-cost short term lending

 

H&T Group plc announced on 18 November 2019 that it was working closely with the Financial Conduct Authority (FCA) to undertake via a skilled person, a review of the lending processes, credit worthiness and affordability assessments within its unsecured high-cost short term (HCST) loans business between April 2014 and October 2019 ("the review").

 

A methodology for conducting the required past book review was developed in close collaboration with the skilled person. Following an initial review by the FCA, "outcomes testing" was undertaken by the skilled person. After further review by the FCA and subsequent development of the methodology, the FCA has confirmed that H&T may now proceed to implementation of the past book review and the resulting customer redress arrangements.

 

Following application of the review methodology, it is considered that a total of c.9,800 HCST loans to c.8,000 customers should not have been granted. This represents 11.5% of HCST loans and 12.6 % of HCST customers during the period. Redress will be paid in respect of these loans in accordance with the methodology, including statutory interest up to 31 March 2022, taking account of any withholding tax.

 

In total, the cost of the redress will amount to £2.1m, of which £1.6m will be paid directly to customers and £0.5m will be by way of an adjustment to the balance of current outstanding loans. On average, eligible customers will receive redress amounting to £264.

 

Customers who are eligible to receive redress either in the form of cash or balance adjustment will be contacted directly, beginning in April 2022. The process is expected to be completed within 12 months.

 

A provision of £2.1m was raised in the Group's financial statements for the year ending 31 December 2021, to cover the cost of this redress. In addition, it is anticipated that professional, operational and implementation costs relating to the review and the redress programme will amount to approximately £0.6m. This has been fully provided for in previous accounting periods.

 

Chris Gillespie, chief executive of H&T said:

 

"The Board of H&T is very aware of the concerns and uncertainly that this review has caused for all stakeholders. We are pleased that the review is now concluded and that the majority of HCST loans granted by H&T are considered to have been lent responsibly.

 

"Customers whose loan should not have been granted and who are due redress, will be contacted directly and we will endeavour to complete the redress programme as quickly as we can, so as not to prolong the uncertainty further.

 

"H&T is committed to providing services which maintain the highest standards of customer care and regulatory compliance, and we have co-operated fully and constructively with the FCA throughout this review. High cost short term unsecured lending no longer forms part of the Group's product offering."

 

END

 

 

Enquiries:

H&T Group plc 

Tel: 020 8225 2797

Chris Gillespie, Chief Executive

Diane Giddy, Chief Financial Officer

 

Shore Capital Ltd (Nominated Adviser and Broker)

Tel: 020 7408 4090

Stephane Auton/ Iain Sexton (Corporate Advisory)

Guy Wiehahn/ Chloë Booker-Triolo (Corporate Broking)

 

Haggie Partners (Public Relations)

Tel: 020 7562 4444

Damian Beeley

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUMCCUPPGAG
Date   Source Headline
11th Jun 20208:44 amRNSNotice of Annual Report Posting
18th May 20207:00 amRNSAGM Results
23rd Apr 20207:00 amRNSDirector Dealings and Issue of Equity
6th Apr 20207:00 amRNSCOVID-19 Update
18th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSAnnual Financial Report
27th Jan 20207:00 amRNSTrading Update and Notice of Results
14th Jan 20207:00 amRNSBoard changes
19th Nov 201912:39 pmRNSNotification of major holdings
18th Nov 20197:00 amRNSFCA review
8th Nov 20194:40 pmRNSSecond Price Monitoring Extn
8th Nov 20194:35 pmRNSPrice Monitoring Extension
7th Nov 20194:40 pmRNSSecond Price Monitoring Extn
7th Nov 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20191:28 pmRNSAdditional Listing
30th Sep 20194:43 pmRNSAcquisition & Trading
18th Sep 20197:00 amRNSExecutive Director
5th Sep 20193:39 pmRNSAdditional Listing
13th Aug 20197:00 amRNSUnaudited Interim Condensed Financial Statements
7th Aug 20192:00 pmRNSNotice of Results
22nd Jul 20193:42 pmRNSFinancial Director
22nd Jul 201911:15 amRNSStephen Fenerty
12th Jul 20191:59 pmRNSNotification of Major Holdings
5th Jul 20195:39 pmRNSNotification of Major Holdings
2nd Jul 20197:00 amRNSResult of Placing
1st Jul 20194:35 pmRNSAcquisition and Placing
21st Jun 20197:00 amRNSNotice of Annual Report Posting
3rd May 20197:00 amRNSResult of AGM
23rd Apr 20197:00 amRNSAdditional Listing
4th Apr 20194:00 pmRNSDirector dealings and issue of equity
12th Mar 20197:00 amRNSPreliminary Results
23rd Jan 20197:00 amRNSTrading Update and Notice of Results
3rd Jan 20197:00 amRNSPerformance Share Plan Awards
21st Nov 20184:21 pmRNSNotification of Major Holdings
10th Oct 201812:00 pmRNSNotification of Major Holdings
11th Sep 20187:00 amRNSDirector/PDMR Shareholding
14th Aug 20187:00 amRNSInterim Results
27th Jul 20184:23 pmRNSIFRS 9 Transition Document
16th Jul 20184:18 pmRNSNotification of Major Holdings
20th Jun 201810:25 amRNSAdditional Listing
14th Jun 20185:32 pmRNSDirector Dealings
13th Jun 201812:19 pmRNSDirector Dealings
29th May 20184:14 pmRNSNotification of Major Holdings
29th May 20187:00 amRNSNotification of Major Holdings
15th May 20187:00 amRNSAdditional Listing
10th May 201810:16 amRNSAGM Results
10th May 20187:00 amRNSAdditional Listing
9th May 20187:00 amRNSBoard Changes
4th Apr 20187:00 amRNSNotice of annual report posting
29th Mar 20184:21 pmRNSDirector Dealings and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.